Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease
Terpos, Evangelos , Morgan, Gareth J. , Dimopoulos, Meletios Α. , Lentzsch, Suzanne , Sezer, Orhan , García‐Sánz, Ramón , Shimizu, Kazuyuki , Turesson, Ingemar , Reiman, Tony , Merlini, Giampaolo , Spencer, Andrew , Leleu, Xavier , Cavo, Michèle , Munshi, Nikhil C. , Durie, Brian G.M. , Roodman, G. David, Drake, Matthew T. , Raje, Noopur , Jurczyszyn, Artur , Rajkumar, S. Vincent , Merlini, Giampaolo , Dimopoulos, Meletios A , Terpos, Evangelos , Garcia-Sanz, Ramon , Morgan, Gareth J

Journal of Clinical Oncology | May 21, 2013 | Volume: 31 | Issue: 18 | Pages: 2347-2357

10.1200/jco.2012.47.7901 | PMID 23690408 Get It

Purpose The aim of the International Myeloma Working Group was to develop practice recommendations for the management of multiple myeloma (MM) –related bone disease. Methodology An interdisciplinary panel of clinical experts on MM and myeloma bone disease developed recommendations based on published data through August 2012. Expert consensus was used to propose additional recommendations in situations where there were insufficient published data. Levels of evidence and grades of recommendations were assigned and approved by panel members. Recommendations Bisphosphonates (BPs) should be considered in all patients with MM receiving first-line antimyeloma therapy, regardless of presence of osteolytic bone lesions on conventional radiography. However, it is unknown if BPs offer any advantage in patients with no bone disease assessed by magnetic resonance imaging or positron emission tomography/computed tomography. Intravenous (IV) zoledronic acid (ZOL) or pamidronate (PAM) is recommended for preventing skeletal-related events in patients with MM. ZOL is preferred over oral clodronate in newly diagnosed patients with MM because of its potential antimyeloma effects and survival benefits. BPs should be administered every 3 to 4 weeks IV during initial therapy. ZOL or PAM should be continued in patients with active disease and should be resumed after disease relapse, if discontinued in patients achieving complete or very good partial response. BPs are well tolerated, but preventive strategies must be instituted to avoid renal toxicity or osteonecrosis of the jaw. Kyphoplasty should be considered for symptomatic vertebral compression fractures. Low-dose radiation therapy can be used for palliation of uncontrolled pain, impending pathologic fracture, or spinal cord compression. Orthopedic consultation should be sought for long-bone fractures, spinal cord compression, and vertebral column instability.
Spontaneous coronary artery dissection: is there a metabolic association?
Liang, Jackson J. , Skalski, Joseph H. , Mankad, Rekha , Liang, Jackson , Mankad, Rekha

Perfusion | May 21, 2013 | Volume: 28 | Issue: 5 | Pages: 457-458

10.1177/0267659113489331 | PMID 23690315 Get It

Spontaneous coronary artery dissection is an uncommon cause of chest pain and acute myocardial infarction, occurring most classically in young women without cardiovascular risk factors. We present a case of a man presenting with chest pain and arrhythmia found to have multivessel spontaneous coronary artery dissection and hyperhomocysteinemia and we raise the possibility of a potential link between the two conditions.
Maternal Mosaicism Confounds the Neonatal Diagnosis of Type 1 Timothy Syndrome
Dufendach, Keith , Giudicessi, John R. , Boczek, Nicole J. , Ackerman, Michael J. , Dufendach, Keith A

Pediatrics | May 21, 2013 | Volume: 131 | Issue: 6 | Pages: e1991-e1995

10.1542/peds.2012-2941 | PMID 23690510 Get It

The presence of 2 distinct populations of somatic or germline cells within a single individual harboring different genotypes is termed mosaicism. Recent reports suggest that parental mosaicism is involved in the heritability of type 1 Timothy syndrome (TS1), an extremely rare and life-threatening multisystem disorder characterized by severe QT interval prolongation, syndactyly, and several other complications. Although full TS1 is caused by a single missense mutation in the CACNA1C-encoded cardiac calcium channel, mosaic TS1 parents can display isolated syndactyly without additional phenotypic manifestations. A newborn boy presented with syndactyly at birth. The presence of syndactyly in his mother led to a diagnosis of benign familial syndactyly. However, at 9 months of age, during his first syndactyly-corrective surgery, intraoperative electrocardiograms revealed extreme QT prolongation and 2:1 atrioventricular block. A comprehensive cardiac evaluation was performed, and both mother and child were tested genetically, confirming a clinical suspicion of TS1. Only the patient tested positive for the TS1 mutation; however, more extensive molecular testing revealed a limited presence of the mutation in maternally-derived DNA. This case illustrates the potential of parental mosaicism to confound the diagnosis of potentially life-threatening genetic diseases, such as TS1. Here, a mother with a partial TS1 phenotype and genetically confirmed mosaicism transmitted the TS1-causative mutation to her son, resulting in fully expressive TS1. Thus, a shared partial phenotype should not be dismissed as a benign or insignificant finding, but should be evaluated further to rule out the possibility of parental mosaicism concealing a potentially fatal heritable disease.
NINDS Stroke Genetics Network (SiGN) Experience with the Causative Classification System
Worrall, Bradford B. , Brown, Robert D. , Ay, Hakan , McArdle, Patrick F. , Kittner, Steven J. , Meschia, James F. , Rundek, Tatjana

International Journal of Stroke | May 21, 2013 | Volume: 8 | Issue: 4 | Pages: E9-E9

10.1111/j.1747-4949.2012.00944.x | PMID 23692494 Get It

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
Veroux, Massimiliano , Tallarita, Tiziano , Corona, Daniela , Sinagra, N., Giaquinta, Alessia, Zerbo, Domenico , Guerrieri, Carmela, D’Assoro, Antonino B. , Cimino, Sebastiano , Veroux, Pierfrancesco

Clinical and Developmental Immunology | May 20, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-7

10.1155/2013/496974 | PMID 23762090 Get It

New-onset diabetes mellitus after transplantation (NODAT) may complicate 2–50% of kidney transplantation, and it is associated with reduced graft and patient survivals. In this retrospective study, we applied a conversion protocol to sirolimus in a cohort of kidney transplant recipients with NODAT. Among 344 kidney transplant recipients, 29 patients developed a NODAT (6.6%) and continued with a reduced dose of calcineurin inhibitors (CNI) (8 patients, Group A) or were converted to sirolimus (SIR) (21 patients, Group B). NODAT resolved in 37.5% and in 80% patients in Group A and Group B, respectively. In Group A, patient and graft survivals were 100% and 75%, respectively, not significantly different from Group B (83.4% and 68%, resp.,P=0.847). Graft function improved after conversion to sirolimus therapy: serum creatinine was 1.8 ± 0.7 mg/dL at the time of conversion and 1.6 ± 0.4 mg/dL five years after conversion to sirolimus therapy (P<0.05), while in the group of patients remaining with a reduced dose of CNI, serum creatinine was 1.7 ± 0.6 mg/dL at the time of conversion and 1.65 ± 0.6 mg/dL at five-year followup (P=0.732). This study demonstrated that the conversion from CNI to SIR in patients could improve significantly the metabolic parameters of patients with NODAT, without increasing the risk of acute graft rejection.
Synaptic vesicle exocytosis
Benarroch, Eduardo E.

Neurology | May 20, 2013 | Volume: 80 | Issue: 21 | Pages: 1981-1988

10.1212/wnl.0b013e318293e3cd | PMID 23690298 Get It

Teaching Neuro Images : “Pancake-like” gadolinium enhancement suggests compressive myelopathy due to spondylosis
Flanagan, Eoin P. , Marsh, Richard W., Weinshenker, Brian G. , Flanagan, E P , Weinshenker, Brian G

Neurology | May 20, 2013 | Volume: 80 | Issue: 21 | Pages: No page available

10.1212/wnl.0b013e318293e346 | PMID 23690303 Get It

Hepatocellular cancer risk in diabetes: Not all diabetics are the same
Singh, Siddharth , Singh, Preet Paul

Hepatology | May 20, 2013 | Volume: 58 | Issue: 6 | Pages: 2207-2208

10.1002/hep.26452 | PMID 23696491 Get It

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators
Lampert, Rachel , Olshansky, Brian , Heidbüchel, Hein , Lawless, Christine E., Saarel, Elizabeth V. , Ackerman, Michael J. , Calkins, Hugh , Maron, Barry J. , Scheinman, Melvin M. , Wilkoff, Bruce L. , Zipes, Douglas P. , Berul, Charles I. , Cheng, Alan , Law, Ian H. , Loomis, Michele, Barth, Cheryl , Dziura, James , Cannom, David S. , Estes, N.A. Mark , Link, Mark S. , Marcus, Gregory M. , Brandt, Cynthia , Li, Fangyong , Olshansky, Brian , Law, Ian H , Zipes, Douglas P

Circulation | May 20, 2013 | Volume: 127 | Issue: 20 | Pages: 2021-2030

10.1161/circulationaha.112.000447 | PMID 23690453 Get It

Background— The risks of sports participation for implantable cardioverter-defibrillator (ICD) patients are unknown. Methods and Results— Athletes with ICDs (age, 10–60 years) participating in organized (n=328) or high-risk (n=44) sports were recruited. Sports-related and clinical data were obtained by phone interview and medical records. Follow-up occurred every 6 months. ICD shock data and clinical outcomes were adjudicated by 2 electrophysiologists. Median age was 33 years (89 subjects <20 years of age); 33% were female. Sixty were competitive athletes (varsity/junior varsity/traveling team). A pre-ICD history of ventricular arrhythmia was present in 42%. Running, basketball, and soccer were the most common sports. Over a median 31-month (interquartile range, 21–46 months) follow-up, there were no occurrences of either primary end point—death or resuscitated arrest or arrhythmia- or shock-related injury—during sports. There were 49 shocks in 37 participants (10% of study population) during competition/practice, 39 shocks in 29 participants (8%) during other physical activity, and 33 shocks in 24 participants (6%) at rest. In 8 ventricular arrhythmia episodes (device defined), multiple shocks were received: 1 at rest, 4 during competition/practice, and 3 during other physical activity. Ultimately, the ICD terminated all episodes. Freedom from lead malfunction was 97% at 5 years (from implantation) and 90% at 10 years. Conclusions— Many athletes with ICDs can engage in vigorous and competitive sports without physical injury or failure to terminate the arrhythmia despite the occurrence of both inappropriate and appropriate shocks. These data provide a basis for more informed physician and patient decision making in terms of sports participation for athletes with ICDs.
Current perspectives and emerging issues on cancer rehabilitation
Stubblefield, Michael D. , Hubbard, Gill , Koch, Uwe , Schmitz, Kathryn H. , Dalton, Susanne Oksbjerg , Cheville, Andrea , Schmitz, Kathryn H

Cancer | May 20, 2013 | Volume: 119 | Issue: S11 | Pages: 2170-2178

10.1002/cncr.28059 | PMID 23695929 Get It

Cancer rehabilitation is a rapidly emerging and evolving medical field in both Europe and the United States, in large part because of increases in the number of cancer survivors. Although few argue with the need to restore function and quality of life to patients affected by cancer and its treatments, differences exist between European countries with regard to the funding, accessibility, and even the definition of cancer rehabilitation services. In the United States, there is tremendous variability in the provision of rehabilitation services resulting from a variety of factors, including a lack of highly trained cancer rehabilitation physicians and therapists as well as a lack of comprehensive cancer rehabilitation programs, even at the majority of top cancer centers. Although studies evaluating the effectiveness of rehabilitation programs in the cancer setting, particularly exercise, have influenced clinical decision‐making in both Europe and the United States for some time, this emerging evidence base also is now starting to influence guideline and policy making. Coordinated research efforts are essential to establish a robust framework to support future investigation and establish shared initiatives. Determining the best way forward for cancer survivors will require investment in large‐scale prospective cohort studies that sufficiently describe their rehabilitation needs through the continuum of the survivorship experience. Cancer 2013;119(11 suppl):2170‐8. © 2013 American Cancer Society.